Humana Inc. (HUM)

Over the past six months, Humana's stock price has decreased by 4.39%. From June 27, 2024, to June 26, 2025, the share price declined by 33.91%. Key events impacting the stock price include higher-than-anticipated utilization trends, preliminary Q4 and Full Year 2023 financial results, Medicare Advantage benchmark rate cuts, Medicare Advantage market exits, and earnings reports. Humana's revenue for the last quarter was $32.11 billion USD, with a net income of $1.24 billion USD. The company is expected to release its next earnings report on July 30, 2025.

Demand seasonality for Humana is driven by annual enrollment periods for health insurance, particularly Medicare. The Medicare Open Enrollment Period runs from October 15 through December 7. The Open Enrollment Period for individual and family health insurance plans typically runs from November 1 to January 15. Individuals can enroll in or change plans during a Special Enrollment Period if they experience a qualifying life event. Humana anticipates higher utilization of supplemental benefits in the latter half of the year, especially in the fourth quarter. Humana expects its second-quarter earnings to represent approximately 37% of its full-year earnings.

Humana Inc. is an American for-profit health insurance and well-being company headquartered in Louisville, Kentucky. Founded in 1961, it has transformed to focus on health insurance products and services, emphasizing Medicare Advantage plans. Humana operates primarily in the United States. Humana's sector is Managed Healthcare and its industry is Insurance. Humana offers health insurance plans including Medicare Advantage, Medicaid, and commercial plans. They also provide healthcare services such as pharmacy services, home health, and primary care. Additionally, they offer specialty products like dental, vision, and life insurance.

Humana operates primarily in the United States, serving millions of members through its medical and specialty insurance segments. The company serves a geographically diverse membership base across all 50 states in the United States and Puerto Rico. Humana is a prominent presence in states like Florida, Illinois, and Puerto Rico for its Medicaid plans. In 2025, Humana offered Medicare Advantage plans in 89% of all counties in the U.S.

Humana's brand reputation has been mixed, with positive reviews for plan options and customer care, but complaints about claims processing and customer service. Humana received positive reviews and high marks for customer satisfaction and affordability. However, there have been complaints about claims processing and poor customer service reviews for Medicare Supplement plans. The MyHumana app has received low scores, and a federal securities class action investigation was announced against Humana Inc. Medicare Advantage companies, including Humana, denied prior authorization requests for post-acute care at higher rates.

Humana Inc. is primarily owned by institutional shareholders, who hold approximately 92.91% of the stock. Individual investors hold about 4.78%, and Humana insiders hold 2.30%. Major institutional owners include Vanguard Group Inc. and BlackRock, Inc.. David A. Jones Sr. is the largest individual Humana shareholder, owning 1.08 million shares, representing 0.89% of the company.